Eli Lilly used its voucher for orforglipron, approved on April 1, 2026, under the brand name Foundayo, and described by the agency as the fastest approval of a new molecular entity since 2002
GLP-1 medications slow gastric emptying, which can affect the absorption rate and timing of oral medications
On average, patients on GLP-1 medication can lose 15% of their body weight in a year.* It is important to remember that results and timelines can vary
That is an exceptionally high satisfaction rate for a telehealth provider in the weight loss space, where customer expectations are high and results vary significantly between individuals
Starting doses are $149/month, but costs increase as you titrate up
After your first month on semaglutide, consider adding the Precision Peptide Genetic Test ($298) to map your unique peptide pathways